real‑world cost
5 Secret Ways Semaglutide Cuts Payer Spend
5 Secret Ways Semaglutide Cuts Payer Spend Semaglutide reduces payer spend by lowering obesity-related admissions, trimming surgery costs, and improving medication adherence. Insurers have reported a 15% drop in obesity-related admissions after adding semaglutide to formularies, showing the drug’s impact on health-system economics. Medical Disclaimer: This article is for